Vamikibart

DB18896InvestigationalProtein Based Therapies

Vamikibart is under investigation in clinical trial NCT05642312 (A Study to Investigate Vamikibart in Participants With Uveitic Macular Edema).

Mechanism
Curator reviewed
Code names
EBI-031 · RO7200220

Resolves to

Compound
UNIIKP04MH1JTTCAS2744320-12-3
Targets
P05231IL6

What you can answer from here — as of July 09, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Vamikibart, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In